Pzena Investment Management LLC lifted its position in Teleflex Incorporated (NYSE:TFX – Free Report) by 84.2% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 699,125 shares of the medical technology company’s stock after acquiring an additional 319,660 shares during the quarter. Pzena Investment Management LLC’s holdings in Teleflex were worth $83,622,000 as of its most recent SEC filing.
Other institutional investors have also made changes to their positions in the company. Ruffer LLP bought a new position in Teleflex during the fourth quarter worth $5,154,000. Waterfront Wealth Inc. bought a new stake in Teleflex during the fourth quarter valued at $2,050,000. Eos Management L.P. bought a new stake in Teleflex during the fourth quarter valued at $3,763,000. Capital International Investors acquired a new stake in shares of Teleflex during the third quarter worth $44,851,000. Finally, Universal Beteiligungs und Servicegesellschaft mbH raised its holdings in shares of Teleflex by 227.5% during the fourth quarter. Universal Beteiligungs und Servicegesellschaft mbH now owns 27,822 shares of the medical technology company’s stock worth $3,395,000 after purchasing an additional 19,327 shares during the period. 95.62% of the stock is currently owned by institutional investors.
Analyst Upgrades and Downgrades
Several research analysts have recently commented on the stock. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Teleflex in a report on Wednesday, June 24th. Piper Sandler raised Teleflex from a “neutral” rating to an “overweight” rating and upped their target price for the company from $140.00 to $160.00 in a report on Monday, June 8th. Zacks Research raised Teleflex from a “strong sell” rating to a “hold” rating in a report on Tuesday, April 28th. Truist Financial restated a “hold” rating and set a $143.00 price objective (up from $135.00) on shares of Teleflex in a research note on Monday, May 11th. Finally, Mizuho set a $140.00 target price on Teleflex in a research report on Friday, May 8th. Four research analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $146.00.
Teleflex Price Performance
Shares of NYSE:TFX opened at $129.89 on Thursday. The firm’s 50 day moving average is $129.85 and its two-hundred day moving average is $119.63. Teleflex Incorporated has a 52 week low of $100.18 and a 52 week high of $139.67. The firm has a market capitalization of $5.75 billion, a P/E ratio of -5.70, a PEG ratio of 0.94 and a beta of 0.82. The company has a current ratio of 2.55, a quick ratio of 2.03 and a debt-to-equity ratio of 0.82.
Teleflex (NYSE:TFX – Get Free Report) last issued its quarterly earnings data on Thursday, May 7th. The medical technology company reported $1.39 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.21 by $0.18. Teleflex had a positive return on equity of 13.29% and a negative net margin of 35.88%.The business had revenue of $548.30 million during the quarter, compared to the consensus estimate of $536.91 million. During the same period in the previous year, the firm posted $1.44 earnings per share. The business’s revenue was up 32.3% on a year-over-year basis. Teleflex has set its FY 2026 guidance at 6.250-6.550 EPS. Analysts anticipate that Teleflex Incorporated will post 6.7 earnings per share for the current year.
Teleflex Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Tuesday, June 30th. Shareholders of record on Monday, May 25th were given a dividend of $0.34 per share. This represents a $1.36 dividend on an annualized basis and a yield of 1.0%. The ex-dividend date was Friday, May 22nd. Teleflex’s payout ratio is -5.96%.
Teleflex Profile
Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.
The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.
Featured Stories
- Five stocks we like better than Teleflex
- AirJoule Unveils Prime System, Clearing Path to Commercialization
- Copper Stocks Are Getting a Bigger Spotlight as Gold’s Rally Cracks
- Nike Q4 Beat Masks Core Weakness as Analysts Cut Price Targets
- Uber’s Waymo Detour Tests the Stock’s Robotaxi Bull Case
Want to see what other hedge funds are holding TFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teleflex Incorporated (NYSE:TFX – Free Report).
Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.
